Adult Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version
SECTIONS
- General Information About Adult Hodgkin Lymphoma (HL)
- Cellular Classification of Adult HL
- Stage Information for Adult HL
- Treatment Option Overview for Adult HL
- Early Favorable Classic HL Treatment
- Early Unfavorable Classic HL Treatment
- Advanced Classic HL Treatment
- Recurrent Adult Classic HL Treatment
- Nodular Lymphocyte–Predominant HL (NLPHL) Treatment
- HL During Pregnancy
- Changes to This Summary (08/15/2018)
- About This PDQ Summary
- View All Sections
Changes to This Summary (08/15/2018)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
This summary was comprehensively reviewed, extensively revised, and reformatted.
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
.png)
No hay comentarios:
Publicar un comentario